据美国《医学论坛报周op年6月24日载Vergan报道，一种新型的免疫抑制剂可使骨髓移植（BMT）更易实施。该药可以改变受体免疫系统，使不太匹配的组织相容。理论上，该药可使受体T细胞不能识别供体组织的异质标志物，但却能识S懒生物和其他感染因子。波士顿市Danar癌症研究所G山n According to the report of Vergan, published on June 24th in the United States Medical Forum Week, a new type of immunosuppressive agent can make bone marrow transplantation (BMT) easier to implement. The drug can alter the recipient’s immune system, making less-matchable tissue compatible. In theory, the drug could make recipient T cells unable to recognize heterogeneous markers of donor tissues, but it could be aware of S lazy organisms and other infectious agents. Danar Cancer Institute of Boston G